UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 223

Sortiert nach

Sibeprenlimab bei Patienten mit IgA-Nephropathie: Phase-II-Studie

Die Nephrologie, 2024-03

Sommerer, Claudia

2024

Link zum Volltext

Verfügbarkeit prüfen

Innovative Therapie der progredienten IgA-Nephropathie mit dem oralen verkapselten Steroidpräparat Nefecon

Die Nephrologie, 2023-05, Vol.18 (3), p.174-176

Sommerer, Claudia

2023

Link zum Volltext

Verfügbarkeit prüfen

Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial

The Lancet (British edition), 2011-03, Vol.377 (9768), p.837-847

2011

Link zum Volltext

Verfügbarkeit prüfen

First-in-human Phase I studies of PRS-080#22, a hepcidin antagonist, in healthy volunteers and patients with chronic kidney disease undergoing hemodialysis

PloS one, 2019-03, Vol.14 (3), p.e0212023

2019

Link zum Volltext

Verfügbarkeit prüfen

Urinary miR‐155‐5p and CXCL10 as prognostic and predictive biomarkers of rejection, graft outcome and treatment response in kidney transplantation

British journal of clinical pharmacology, 2017-12, Vol.83 (12), p.2636-2650

2017

Link zum Volltext

Verfügbarkeit prüfen

Early prognostic performance of miR155-5p monitoring for the risk of rejection: Logistic regression with a population pharmacokinetic approach in adult kidney transplant patients

PloS one, 2021-01, Vol.16 (1), p.e0245880

2021

Link zum Volltext

Verfügbarkeit prüfen

Application of the iBox prognostication system as a surrogate endpoint in the TRANSFORM randomised controlled trial: proof-of-concept study

BMJ open, 2021-10, Vol.11 (10), p.e052138-e052138

2021

Link zum Volltext

Verfügbarkeit prüfen

Comparing mycophenolate mofetil regimens for de novo renal transplant recipients: the fixed-dose concentration-controlled trial

Transplantation, 2008-10, Vol.86 (8), p.1043

2008

Link zum Volltext

Verfügbarkeit prüfen

Clinical Manifestation and Management of ADPKD in Western Countries

Kidney diseases, 2016-10, Vol.2 (3), p.120-127

2016

Link zum Volltext

Verfügbarkeit prüfen

Reporting Quality-of-Life Outcomes in Clinical Trials of Immunosuppressive Therapy in Kidney Transplantation

American journal of kidney diseases, 2016-05, Vol.67 (5), p.722-723

2016

Link zum Volltext

Verfügbarkeit prüfen

Overhydration Is a Strong Predictor of Mortality in Peritoneal Dialysis Patients - Independently of Cardiac Failure

PloS one, 2016-07, Vol.11 (7), p.e0158741-e0158741

2016

Link zum Volltext

Verfügbarkeit prüfen

Barcelona Consensus on Biomarker-Based Immunosuppressive Drugs Management in Solid Organ Transplantation

Therapeutic drug monitoring, 2016-04, Vol.38 Suppl 1, p.S1

2016

Link zum Volltext

Verfügbarkeit prüfen

Everolimus in de novo kidney transplant recipients participating in the Eurotransplant senior program: Results of a prospective randomized multicenter study (SENATOR)

PloS one, 2019-09, Vol.14 (9), p.e0222730-e0222730

2019

Link zum Volltext

Verfügbarkeit prüfen

Common T-Cell-Receptor Motifs and Features in Patients with Cytomegalovirus (CMV)-Seronegative End-Stage Renal Disease Receiving a Peptide Vaccination against CMV

International journal of molecular sciences, 2022-01, Vol.23 (3), p.1029

2022

Link zum Volltext

Verfügbarkeit prüfen

Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) study

PloS one, 2018-08, Vol.13 (8), p.e0202604-e0202604

2018

Link zum Volltext

Verfügbarkeit prüfen

Correlation between pharmacokinetics of tacrolimus and pharmacodynamics on NFAT-regulated gene expression in stable kidney transplant recipients

Clinical nephrology, 2017-02, Vol.87 (2017) (2), p.93

2017

Link zum Volltext

Verfügbarkeit prüfen

Five-year follow-up of a phase I trial of donor-derived modified immune cell infusion in kidney transplantation

Frontiers in immunology, 2023-07, Vol.14, p.1089664-1089664

2023

Link zum Volltext

Verfügbarkeit prüfen

Gender disparity in health-related quality of life and fatigue after living renal donation

BMC nephrology, 2018-12, Vol.19 (1), p.377-377, Article 377

2018

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic and pharmacodynamic analysis of enteric‐coated mycophenolate sodium: limited sampling strategies and clinical outcome in renal transplant patients

British journal of clinical pharmacology, 2010-04, Vol.69 (4), p.346-357

2010

Link zum Volltext

Verfügbarkeit prüfen

Individualised immunosuppression with intravenously administered donor-derived modified immune cells compared with standard of care in living donor kidney transplantation (TOL-2 Study): protocol for a multicentre, open-label, phase II, randomised controlled trial

BMJ open, 2022-11, Vol.12 (11), p.e066128-e066128

2022

Link zum Volltext

Verfügbarkeit prüfen

Pharmacodynamic monitoring of cyclosporin A reveals risk of opportunistic infections and malignancies in renal transplant recipients 65 years and older

Therapeutic drug monitoring, 2011-12, Vol.33 (6), p.694

2011

Link zum Volltext

Verfügbarkeit prüfen

Everolimus plus reduced calcineurin inhibitor prevents de novo anti-HLA antibodies and humoral rejection in kidney transplant recipients: 12-month results from the ATHENA study

Frontiers in transplantation, 2023-10, Vol.2, p.1264903

2023

Link zum Volltext

Verfügbarkeit prüfen

Renal, efficacy and safety outcomes following late conversion of kidney transplant patients from calcineurin inhibitor therapy to everolimus: the randomized APOLLO study

Clinical nephrology, 2015-01, Vol.83 (1), p.11

2015

Link zum Volltext

Verfügbarkeit prüfen

Ciclosporin A tapering monitored by NFAT-regulated gene expression: a new concept of individual immunosuppression

Transplantation, 2008-01, Vol.85 (1), p.15

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 223

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(188)
Mit Volltextzugriff
(181)

Publikationsform

Artikel
(194)
Buchkapitel
(18)
Bücher
(11)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(151)
Life Sciences & Biomedicine
(144)
Humans
(115)
Transplantation
(74)
Male
(70)
Female
(66)
Middle Aged
(60)
Urology & Nephrology
(57)
Adult
(56)
Kidney Transplantation
(50)
Aged
(49)
Biological And Medical Sciences
(35)
Immunosuppressive Agents - Therapeutic Use
(34)
Medical Sciences
(33)
Surgery
(33)
Prospective Studies
(29)
Immunology
(28)
Immunosuppression
(28)
Renal Transplantation
(26)
Transplants & Implants
(25)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report

Sibeprenlimab bei Patienten mit IgA-Nephropathie: Phase-II-Studie

Innovative Therapie der progredienten IgA-Nephropathie mit dem oralen verkapselten Steroidpräparat Nefecon

Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial

First-in-human Phase I studies of PRS-080#22, a hepcidin antagonist, in healthy volunteers and patients with chronic kidney disease undergoing hemodialysis

Urinary miR‐155‐5p and CXCL10 as prognostic and predictive biomarkers of rejection, graft outcome and treatment response in kidney transplantation

Early prognostic performance of miR155-5p monitoring for the risk of rejection: Logistic regression with a population pharmacokinetic approach in adult kidney transplant patients

Application of the iBox prognostication system as a surrogate endpoint in the TRANSFORM randomised controlled trial: proof-of-concept study

Comparing mycophenolate mofetil regimens for de novo renal transplant recipients: the fixed-dose concentration-controlled trial

Clinical Manifestation and Management of ADPKD in Western Countries

Reporting Quality-of-Life Outcomes in Clinical Trials of Immunosuppressive Therapy in Kidney Transplantation

Overhydration Is a Strong Predictor of Mortality in Peritoneal Dialysis Patients - Independently of Cardiac Failure

Barcelona Consensus on Biomarker-Based Immunosuppressive Drugs Management in Solid Organ Transplantation

Everolimus in de novo kidney transplant recipients participating in the Eurotransplant senior program: Results of a prospective randomized multicenter study (SENATOR)

Common T-Cell-Receptor Motifs and Features in Patients with Cytomegalovirus (CMV)-Seronegative End-Stage Renal Disease Receiving a Peptide Vaccination against CMV

Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) study

Correlation between pharmacokinetics of tacrolimus and pharmacodynamics on NFAT-regulated gene expression in stable kidney transplant recipients

Five-year follow-up of a phase I trial of donor-derived modified immune cell infusion in kidney transplantation

Gender disparity in health-related quality of life and fatigue after living renal donation

Pharmacokinetic and pharmacodynamic analysis of enteric‐coated mycophenolate sodium: limited sampling strategies and clinical outcome in renal transplant patients

Individualised immunosuppression with intravenously administered donor-derived modified immune cells compared with standard of care in living donor kidney transplantation (TOL-2 Study): protocol for a multicentre, open-label, phase II, randomised controlled trial

Pharmacodynamic monitoring of cyclosporin A reveals risk of opportunistic infections and malignancies in renal transplant recipients 65 years and older

Everolimus plus reduced calcineurin inhibitor prevents de novo anti-HLA antibodies and humoral rejection in kidney transplant recipients: 12-month results from the ATHENA study

Renal, efficacy and safety outcomes following late conversion of kidney transplant patients from calcineurin inhibitor therapy to everolimus: the randomized APOLLO study

Ciclosporin A tapering monitored by NFAT-regulated gene expression: a new concept of individual immunosuppression

Suchergebnisse filtern